These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8233504)

  • 1. Diuretic and diet effect on Menière's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines.
    Santos PM; Hall RA; Snyder JM; Hughes LF; Dobie RA
    Otolaryngol Head Neck Surg; 1993 Oct; 109(4):680-9. PubMed ID: 8233504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AAO-HNS Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease: have they been applied in the published literature of the last decade?
    Thorp MA; Shehab ZP; Bance ML; Rutka JA;
    Clin Otolaryngol Allied Sci; 2003 Jun; 28(3):173-6. PubMed ID: 12755750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical indicators useful in predicting response to the medical management of Meniere's disease.
    Devaiah AK; Ator GA
    Laryngoscope; 2000 Nov; 110(11):1861-5. PubMed ID: 11081600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS; Lai JT
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interpretation of clinical practice guideline: Ménière's disease （2020）].
    Yu H; Li H; Li Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 May; 35(5):385-390. PubMed ID: 34304459
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic criteria for Menière's disease.
    Lopez-Escamez JA; Carey J; Chung WH; Goebel JA; Magnusson M; Mandalà M; Newman-Toker DE; Strupp M; Suzuki M; Trabalzini F; Bisdorff A; ; ; ; ;
    J Vestib Res; 2015; 25(1):1-7. PubMed ID: 25882471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of Menière's disease.
    Jackson CG; Glasscock ME; Davis WE; Hughes GB; Sismanis A
    Ann Otol Rhinol Laryngol; 1981; 90(2 Pt 1):142-7. PubMed ID: 7224512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP; Din S; Atlas MD
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of symptoms in patients with Meniere's disease using middle ear pressure applications: two years follow-up.
    Densert B; Sass K
    Acta Otolaryngol; 2001 Jul; 121(5):616-21. PubMed ID: 11583396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary modification as adjunct treatment in Ménière's disease: patient willingness and ability to comply.
    Luxford E; Berliner KI; Lee J; Luxford WM
    Otol Neurotol; 2013 Oct; 34(8):1438-43. PubMed ID: 23965526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical hints and precipitating factors in patients suffering from Meniere's disease.
    Rauch SD
    Otolaryngol Clin North Am; 2010 Oct; 43(5):1011-7. PubMed ID: 20713240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of second-echelon treatments for Ménière's disease.
    Basura GJ; Lin GC; Telian SA
    JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):754-61. PubMed ID: 25057891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior fossa vestibular neurotomy as primary surgical treatment of Menière's disease: a re-evaluation.
    Pareschi R; Destito D; Falco Raucci A; Righini S; Colombo S
    J Laryngol Otol; 2002 Aug; 116(8):593-6. PubMed ID: 12389685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
    Shea PF; Richey PA; Wan JY; Stevens SR
    Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.